Cardax Profile

0.19
USD 0.02  9.52%
0%
0%

Purchase by Vbi Vaccines Inc 1 of 500000 shares of Cardax

Cardax insider trading alert for perchase of common stock by Vbi Vaccines Inc 1, the corporate stakeholder, on August 20, 2018. This event was filed by Cardax Inc with SEC on 2014-05-09. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Cardax Summary

Cardax [CDXI] is traded as part of a regulated electronic over-the-counter service offered by the NASD. Cardax is listed under Restaurants Hotels Motels category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with current market capitalization of 25.46 M. Cardax conducts business under Healthcare sector and is part of Biotechnology industry. This company has 123.02 M outstanding shares. CARDAX currently holds about 1.41 M in cash with (2.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Cardax Probability Of Bankruptcy

Ownership Allocation (%)

Cardax Target Price Odds Analysis

Odds Below 0.19HorizonTargetOdds Above 0.19
9.06%30 days 0.19 90.84%
Based on normal probability distribution, the odds of Cardax to move above current price in 30 days from now is about 90.84% (This Cardax probability density function shows the probability of Cardax OTC Stock to fall within a particular range of prices over 30 days) .

Cardax Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Cardax Key Fundamentals

Cardax Against Markets

Cardax Current Ratings

Cardax 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
50 
Equity ratings for Cardax are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Cardax, Inc., a life sciences company, develops and commercializes consumer health and pharmaceutical products for anti-inflammatory benefits primarily in Hawaii. Cardax, Inc. was incorporated in 2012 and is based in Honolulu, Hawaii. Cardax operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 11 people. more
Fama & French Restaurants Hotels Motels
Restaurants Hotels Motels
Fama & French Classification
Cardax SEC Filings
Cardax SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameCardax
Executive ChairmanNicholas MitsakosView All
Thematic Classification
Currently Active Investing Idea
Restaurants Hotels Motels
  Restaurants Hotels Motels
View All
Macroaxis Advice
Specialization
Consumer Cyclical, Restaurants
InstrumentUSA OTC Stock View All
LocationHAWAII U.S.A
Business Address2800 Woodlawn Drive
ExchangeBATS Exchange
CUSIP14141D102
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.cardaxpharma.com
Phone808 457 1400
CurrencyUSD - US Dollar

Did you try this?

Run My Watchlist Analysis Now

   

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch My Watchlist Analysis

Cardax Directors

Cardax Corporate Directors

George Bickerstaff Independent Director
Tamar Howson Independent Director
Elona Kogan Independent Director
Check also Trending Equities. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.
Search macroaxis.com